Literature DB >> 12071509

Stress and depression: possible links to neuron death in the hippocampus.

Angela L Lee1, William O Ogle, Robert M Sapolsky.   

Abstract

Recent intriguing reports have shown an association between major depression and selective and persistent loss of hippocampal volume, prompting considerable speculation as to its underlying causes. In this paper we focus on the hypothesis that overt hippocampal neuron death could cause this loss and review current knowledge about how hippocampal neurons die during insults. We discuss (a) the trafficking of glutamate and calcium during insults; (b) oxygen radical generation and programmed cell death occurring during insults; (c) neuronal defenses against insults; (d) the role of energy availability in modulating the extent of neuron loss following such insults. The subtypes of depression associated with hippocampal atrophy typically involve significant hypersecretion of glucocorticoids, the adrenal steroids secreted during stress. These steroids have a variety of adverse affects, direct and indirect, in the hippocampus. Thus glucocorticoids may play a contributing role toward neuron death. We further discuss how glucocorticoids cause or exacerbate cellular changes associated with hippocampal neuron loss in the context of the events listed above.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12071509     DOI: 10.1034/j.1399-5618.2002.01144.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  97 in total

Review 1.  Depression, antidepressants, and neurogenesis: a critical reappraisal.

Authors:  Nicola D Hanson; Michael J Owens; Charles B Nemeroff
Journal:  Neuropsychopharmacology       Date:  2011-09-21       Impact factor: 7.853

2.  Chronic variable stress impairs energy metabolism in prefrontal cortex and hippocampus of rats: prevention by chronic antioxidant treatment.

Authors:  Bárbara Tagliari; Cristie G Noschang; Andréia G K Ferreira; Otávio A Ferrari; Luciane R Feksa; Clovis M D Wannmacher; Carla Dalmaz; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2010-05-27       Impact factor: 3.584

3.  Volumetric MRI analysis of the amygdala and hippocampus in subjects with major depression.

Authors:  Jun Xia; Jun Chen; Yicheng Zhou; Jingfeng Zhang; Bo Yang; Liming Xia; Chengyuan Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

Review 4.  11beta-HSD1, inflammation, metabolic disease and age-related cognitive (dys)function.

Authors:  Karen E Chapman; Jonathan R Seckl
Journal:  Neurochem Res       Date:  2007-10-25       Impact factor: 3.996

5.  Concentration dependent actions of glucocorticoids on neuronal viability and survival.

Authors:  István M Abrahám; Peter Meerlo; Paul G M Luiten
Journal:  Dose Response       Date:  2006-06-20       Impact factor: 2.658

6.  Prospective reports of chronic life stress predict decreased grey matter volume in the hippocampus.

Authors:  Peter J Gianaros; J Richard Jennings; Lei K Sheu; Phil J Greer; Lewis H Kuller; Karen A Matthews
Journal:  Neuroimage       Date:  2007-02-01       Impact factor: 6.556

7.  Hippocampal shape deformation in female patients with unremitting major depressive disorder.

Authors:  W S Tae; S S Kim; K U Lee; E C Nam; J W Choi; J I Park
Journal:  AJNR Am J Neuroradiol       Date:  2011-03-03       Impact factor: 3.825

Review 8.  Update on stress and depression: the role of the hypothalamic-pituitary-adrenal (HPA) axis.

Authors:  Andrea de Abreu Feijó de Mello; Marcelo Feijó de Mello; Linda L Carpenter; Lawrence H Price
Journal:  Braz J Psychiatry       Date:  2004-01-15       Impact factor: 2.697

Review 9.  Neuropeptides in depression: role of VGF.

Authors:  Smita Thakker-Varia; Janet Alder
Journal:  Behav Brain Res       Date:  2008-10-15       Impact factor: 3.332

10.  The New Inhibitor of Monoamine Oxidase, M30, has a Neuroprotective Effect Against Dexamethasone-Induced Brain Cell Apoptosis.

Authors:  Shakevia Johnson; Shawna Tazik; Deyin Lu; Chandra Johnson; Moussa B H Youdim; Junming Wang; Grazyna Rajkowska; Xiao-Ming Ou
Journal:  Front Neurosci       Date:  2010-11-02       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.